Preview

The Pharmaceutical Industry And Health Professional Services

Good Essays
Open Document
Open Document
729 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
The Pharmaceutical Industry And Health Professional Services
My strategy as a health care administrator communicating with Get Well Drugs is to evaluate new drugs before they can be sold. Center for Drug Evaluation and Research (CDER's) evaluation not only prevents quackery, but also provides doctors and patients the information they need to use medicines wisely. The center ensures that drugs, both brand-name and generic, work correctly and that their health benefits outweigh their known risks. First, I will test the drug to make sure it is safe and effective for its intended use. A team of CDER physicians, statisticians, chemists, pharmacologists, and other scientists reviews the company's data and proposed labeling. If this independent and unbiased review establishes that a drug's health benefits outweigh its known risks, the drug is approved for sale. The center will not actually test the drugs, although it does conduct limited research in the areas of drug quality, safety, and effectiveness standards.
Before a drug can be tested in people, the drug company or sponsor performs laboratory and animal tests to discover how the drug works and whether it's likely to be safe and work well in humans. Next, a series of tests in people is begun to determine whether the drug is safe when used to treat a disease and whether it provides a real health benefit. Clinical trials are experiments that use human subjects to see whether a drug is effective, and what side effects it may cause.
New drugs, like other new products, are frequently under patent protection during development. When the patents or other periods of exclusivity on brand-name drugs expire, manufacturers can apply to the FDA to sell generic versions. If FDA finds a problem, it can order a”clinical hold" to delay an investigation, or interrupt a clinical trial if problems occur during the study. I would ask questions directed toward Get Well drugs such as; Does the FDA require that animals of both sexes be included in non-clinical studies? The difference between

You May Also Find These Documents Helpful

  • Better Essays

    GlaxoSmithKline is a U.K.-based pharmaceutical powerhouse formed by a merger in the late 90’s, with the most important merger being that between Glaxo Wellcome and Smith Kline Beecham. The merger created a pharmaceutical industry giant with operations in over 100 countries and annual sales over $25 billion. In the U.S. alone, prescription drugs account for 10% of all medical costs with sales tripling over the past decade and price increases of 150 percent.…

    • 958 Words
    • 4 Pages
    Better Essays
  • Good Essays

    CPOE systems are generally paired with some type of Clinical Decision Support System, or CDSS. A typical CDSS could or would suggest default doses for some drugs, administrative routes, and or even off more sophisticated drug safety features. This would include; drug allergies, or drug to drug, or drug to…

    • 417 Words
    • 2 Pages
    Good Essays
  • Satisfactory Essays

    BIO 275 AP 1

    • 707 Words
    • 2 Pages

    Phase I usually lasts 1 ½ years. Drug Company or sponsor conduct the study on 10 to 100 volunteers who don’t have any medical conditions. Company must to provide the inform consent where has to be included all possible risks and known effects of the new drug. During phase I is studied the correct dose, side effects and the possible toxicity. During the test volunteers are provided with medical examinations. Also this part of the testing a pharmacokinetics are studied as well.…

    • 707 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    Pharmacology Review Sheet

    • 11954 Words
    • 48 Pages

    Before marketing a new drug, the drug company asks the FDA to approve its choice of:…

    • 11954 Words
    • 48 Pages
    Powerful Essays
  • Powerful Essays

    PharmaCare essay

    • 3754 Words
    • 16 Pages

    The twenty-first century has seen pharmaceutical companies grow in unprecedented size and strength. Due to the unprecedented growth the larger pharmaceutical companies have gained leverage and power in the prescription drug industry, but they lack innovation to market and they seek ways to help the business continue to increase its profits. The pharmaceutical industry was once ethically sound and was a valuable player in the development of human health. However, overtime with the lack of innovation pharmaceutical companies are becoming an unethical market that exploits patients, doctors and anyone else it can to increase its profitability. With eyes only on profitability this can create a hazard for patients because there is deficient testing of the drugs prior to the drugs hitting the American market. In this research paper we will cover the many facets of PharmaCare, Coleria, and Wellco and the drug AD23 side effects, and its manufacturing in an impoverished nation with the low wages and unsafe working conditions. All of which will be covered throughout this document.…

    • 3754 Words
    • 16 Pages
    Powerful Essays
  • Satisfactory Essays

    Questions 6

    • 535 Words
    • 2 Pages

    The regulatory and legal issues related to drug and pharmaceutical development and sale is very complex. In order for the FDA to approve this drug for sale it must go through a very long lengthy process of it being approved. This long process can be costly and is considered highly risky. To achieve the point where you can sell your drug, the drug company must go through drug discover and testing. This is when thousands of scientists are employed to test the drug and do clinical testing. Once you pass the rigorous process of the FDA guidelines, your drug will then go through post approval safety and marketing. During this process, safety monitoring becomes a big issue. Next is labeling, advertising and promotional claims. Legal issues can occur during clinical testing to when the drug is out for the public to use.…

    • 535 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    References: Byerly, W. (2009). Working with the institutional review board. American Journal of Health-System Pharmacy: AJHP: Official Journal Of The American Society Of Health System Pharmacists, 66(2), 176-184. Retrieved from http://library.kaplan.edu/content.php?pid=150035…

    • 690 Words
    • 3 Pages
    Good Essays
  • Better Essays

    Treviño, L. K., & Nelson, K. A. (2007). Managing business ethics: Straight talk about how to do it right (4th ed.). Hoboken, NJ: Wiley.…

    • 1342 Words
    • 6 Pages
    Better Essays
  • Powerful Essays

    CQC’s outcome 9 – management of medicines – puts in place the essential standards of quality and safety.…

    • 2042 Words
    • 9 Pages
    Powerful Essays
  • Better Essays

    Fda Research Paper

    • 2368 Words
    • 10 Pages

    Americans must wait up to 19 years after a discovered treatment before they can participate in benefits of a new medication (Philipson & Sun, 2008). The regulatory process drug manufacturers need to endure before releasing potentially life-saving medication is an extremely expensive, time-consuming process. The Center for Drug Evaluation and Research (CDER) is the main department of the Food and Drug Administration (FDA) responsible for the safety of drugs (both prescription and over-the-counter) sold in the United States (Food and Drug Administration, 2011). This department scrutinizes the testing of new drugs and determines if they are safe and effective before distribution. They do not perform in-house testing themselves; they only evaluate the testing done by the manufacturer to make sure the drug claim is accurate and that the benefits of the medication out way the side-effects (Food and Drug Administration, 2011). Whereas the FDA’s regulation and oversight protects dangerous products from circulation, the approval process hinders manufacturers’ ability to release drugs in a timely manner because of the legal and cost liability, thus preventing the availability of treatment to Americans.…

    • 2368 Words
    • 10 Pages
    Better Essays
  • Powerful Essays

    Communication Coordinator

    • 1323 Words
    • 6 Pages

    The U.S. Drug and Food Administration’s Center for Drug Evaluation and Research (CDER), is a unit responsible for validating that all drugs marketed in the United States are safe and effective (FDA, 2010). According to the Food and Drug Administration, “CDER does not test drugs, although the Center's Office of Testing and Research does conduct limited research in the areas of drug quality, safety, and effectiveness” (FDA, 2010). To market a medication to the public and health care establishments, Essie Pharmaceuticals…

    • 1323 Words
    • 6 Pages
    Powerful Essays
  • Good Essays

    I will incorporate the right medication, by checking and double checking labels and orders and making sure that the right medication is given to the right patient. I will also compare the prescriber’s orders with the medication administration record when it is first ordered. Then when preparing the medication I will compare the label of the medication with the medication administration record three different times; first before removing the container, second as the medication is being removed from the container and lastly at the bedside of the patient before administering the medication. There are many drugs that are spelled almost the same, but this does not mean that they are the same drug or that they are interchangeable. (Patricia A. Potter, 2013)…

    • 1285 Words
    • 3 Pages
    Good Essays
  • Good Essays

    The Center for Drug Evaluation and Research(C.D.E.R) is a division of the U.S. Food and Drug Administration that keeps an eye on most drugs as defined in the Drug, Food, and Cosmetic Act. The The Center for Food Safety and Applied Nutrition(C.D.F.A.N) is part of the division is part of the agency because it regulates the food, and dietary supplements. The National Center for Toxicological Research(N.C.T.R) is also apart of the FDA because it does research to define biological mechanisms of toxicity of products. Each of these is apart of the FDA and prevents any harm to the public. They are doing their job and keeping the public…

    • 526 Words
    • 3 Pages
    Good Essays
  • Better Essays

    trials of investigation medical products. The FDA also has to review and approve in a…

    • 1228 Words
    • 5 Pages
    Better Essays
  • Good Essays

    Before approving the sales of a newly discovered drug the U.S. Food and Drug Administration requires that the drug be put through three phases of tests after being tested on animals. In phase one the drug is taken by healthy human individuals to determine whether it has any dangerous side effects. In phase two the drug is given to a small number of sick patients to determine dosage levels .in phase three the drug is given to large number of sick patients by doctors and hospitals to determine its efficacy.…

    • 995 Words
    • 4 Pages
    Good Essays